Click here to get full coverage on Lilly Sues Cipla to Block Copy of Breast Cancer Drug Verzenio - Bloomberg Law News

Lilly Sues Cipla to Block Copy of Breast Cancer Drug Verzenio  Bloomberg Law News

Lilly Sues Cipla to Block Copy of Breast Cancer Drug Verzenio - Bloomberg Law News

Click here to get full coverage on Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA - Yahoo Finance

Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA  Yahoo Finance

Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA - Yahoo Finance

Click here to get full coverage on Cipla Appoints Shivam Puri As CEO Of One India Business - BW Healthcare World

Cipla Appoints Shivam Puri As CEO Of One India Business  BW Healthcare World

Cipla Appoints Shivam Puri As CEO Of One India Business - BW Healthcare World

Click here to get full coverage on cipla invests 4 000 cr to expand global specialty respiratory manufacturing files 10 usfda apps - ICICI Direct

cipla invests 4 000 cr to expand global specialty respiratory manufacturing files 10 usfda apps  ICICI Direct

cipla invests 4 000 cr to expand global specialty respiratory manufacturing files 10 usfda apps - ICICI Direct

Click here to get full coverage on Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis - PR Newswire

Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis  PR Newswire

Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis - PR Newswire

Click here to get full coverage on Cipla Taps Shivam Puri As CEO Of One India Business - BW Marketing World

Cipla Taps Shivam Puri As CEO Of One India Business  BW Marketing World

Cipla Taps Shivam Puri As CEO Of One India Business - BW Marketing World

Click here to get full coverage on Shivam Puri To Lead Cipla’s One India Business From July - BW People

Shivam Puri To Lead Cipla’s One India Business From July  BW People

Shivam Puri To Lead Cipla’s One India Business From July - BW People

Click here to get full coverage on Cipla Taps Shivam Puri to Drive Growth of One India Business - Medical Dialogues

Cipla Taps Shivam Puri to Drive Growth of One India Business  Medical Dialogues

Cipla Taps Shivam Puri to Drive Growth of One India Business - Medical Dialogues

Click here to get full coverage on Cipla expands respiratory, specialty manufacturing across India, China, US - Business Standard

Cipla expands respiratory, specialty manufacturing across India, China, US  Business Standard

Cipla expands respiratory, specialty manufacturing across India, China, US - Business Standard

Click here to get full coverage on India's Cipla posts steeper-than-expected quarterly profit slump on tumour drug supply crunch - Reuters

India's Cipla posts steeper-than-expected quarterly profit slump on tumour drug supply crunch  Reuters

India's Cipla posts steeper-than-expected quarterly profit slump on tumour drug supply crunch - Reuters

Click here to get full coverage on Cipla Elevates Shivam Puri as Chief Executive Officer, One India Business - hrtoday.in

Cipla Elevates Shivam Puri as Chief Executive Officer, One India Business  hrtoday.in

Cipla Elevates Shivam Puri as Chief Executive Officer, One India Business - hrtoday.in

Click here to get full coverage on Cipla, Sun Pharma, Dr Reddy's, Glenmark trade lower after Centre tightens cough syrup sales rules - Moneycontrol.com

Cipla, Sun Pharma, Dr Reddy's, Glenmark trade lower after Centre tightens cough syrup sales rules  Moneycontrol.com

Cipla, Sun Pharma, Dr Reddy's, Glenmark trade lower after Centre tightens cough syrup sales rules - Moneycontrol.com

Click here to get full coverage on Cipla appoints Shivam Puri as CEO of One India Business - People Matters Media

Cipla appoints Shivam Puri as CEO of One India Business  People Matters Media

Cipla appoints Shivam Puri as CEO of One India Business - People Matters Media

Click here to get full coverage on Cipla appoints Shivam Puri as CEO of One India Business - bestmediainfo.com

Cipla appoints Shivam Puri as CEO of One India Business  bestmediainfo.com

Cipla appoints Shivam Puri as CEO of One India Business - bestmediainfo.com

Click here to get full coverage on Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy - PR Newswire

Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy  PR Newswire

Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy - PR Newswire

Click here to get full coverage on Cipla names Shivam Puri to lead India business in key consumer-to-core pharma leadership move - Storyboard18

Cipla names Shivam Puri to lead India business in key consumer-to-core pharma leadership move  Storyboard18

Cipla names Shivam Puri to lead India business in key consumer-to-core pharma leadership move - Storyboard18

Click here to get full coverage on Cipla Flips Gilead’s ‘End Run’ Claim in Descovy Patent Fight - news.bloombergtax.com

Cipla Flips Gilead’s ‘End Run’ Claim in Descovy Patent Fight  news.bloombergtax.com

Cipla Flips Gilead’s ‘End Run’ Claim in Descovy Patent Fight - news.bloombergtax.com

Click here to get full coverage on UCB Defeats Cipla Bid to Nix Patents for Nayzilam Seizure Spray - Bloomberg Law News

UCB Defeats Cipla Bid to Nix Patents for Nayzilam Seizure Spray  Bloomberg Law News

UCB Defeats Cipla Bid to Nix Patents for Nayzilam Seizure Spray - Bloomberg Law News

Click here to get full coverage on Cipla gains FDA OK for generic Ofev - Drug Store News

Cipla gains FDA OK for generic Ofev  Drug Store News

Cipla gains FDA OK for generic Ofev - Drug Store News

Click here to get full coverage on Cipla appoints Shivam Puri as CEO of One India Business - Exchange4Media

Cipla appoints Shivam Puri as CEO of One India Business  Exchange4Media

Cipla appoints Shivam Puri as CEO of One India Business - Exchange4Media

Click here to get full coverage on Cipla appoints Shivam Puri as CEO of 'One India Business' from July 1 - Business Standard

Cipla appoints Shivam Puri as CEO of 'One India Business' from July 1  Business Standard

Cipla appoints Shivam Puri as CEO of 'One India Business' from July 1 - Business Standard

Click here to get full coverage on Cipla Appoints Shivam Puri as CEO of One India Business - IndiaMedToday

Cipla Appoints Shivam Puri as CEO of One India Business  IndiaMedToday

Cipla Appoints Shivam Puri as CEO of One India Business - IndiaMedToday

Click here to get full coverage on Cipla Files FY26 Business Responsibility and Sustainability Report - The Globe and Mail

Cipla Files FY26 Business Responsibility and Sustainability Report  The Globe and Mail

Cipla Files FY26 Business Responsibility and Sustainability Report - The Globe and Mail

Click here to get full coverage on Cipla appoints Shivam Puri as CEO – One India Business effective July 1, 2026 - scanx.trade

Cipla appoints Shivam Puri as CEO – One India Business effective July 1, 2026  scanx.trade

Cipla appoints Shivam Puri as CEO – One India Business effective July 1, 2026 - scanx.trade

Click here to get full coverage on Gilead Accuses Cipla of Sidestepping Earlier Descovy Patent Deal - Bloomberg Law News

Gilead Accuses Cipla of Sidestepping Earlier Descovy Patent Deal  Bloomberg Law News

Gilead Accuses Cipla of Sidestepping Earlier Descovy Patent Deal - Bloomberg Law News

Click here to get full coverage on Cipla introduces generic Saxenda - Drug Store News

Cipla introduces generic Saxenda  Drug Store News

Cipla introduces generic Saxenda - Drug Store News

Click here to get full coverage on Eli Lilly allows Cipla to sell weight loss drug under new brand in India - Reuters

Eli Lilly allows Cipla to sell weight loss drug under new brand in India  Reuters

Eli Lilly allows Cipla to sell weight loss drug under new brand in India - Reuters

Click here to get full coverage on Shivam Puri appointed CEO of Cipla’s One India business effective July 1, 2026 - Mediabrief.com

Shivam Puri appointed CEO of Cipla’s One India business effective July 1, 2026  Mediabrief.com

Shivam Puri appointed CEO of Cipla’s One India business effective July 1, 2026 - Mediabrief.com

Click here to get full coverage on Cipla Health Strengthens ProlyteORS Portfolio with Launch of Masala Guava Flavour - Yahoo Finance

Cipla Health Strengthens ProlyteORS Portfolio with Launch of Masala Guava Flavour  Yahoo Finance

Cipla Health Strengthens ProlyteORS Portfolio with Launch of Masala Guava Flavour - Yahoo Finance

Click here to get full coverage on Cipla appoints Shivam Puri as CEO of One India Business - Adgully.com

Cipla appoints Shivam Puri as CEO of One India Business  Adgully.com

Cipla appoints Shivam Puri as CEO of One India Business - Adgully.com

Click here to get full coverage on Cipla bets on innovation for 10% revenue share; expands US manufacturing to de-risk supply chains - Storyboard18

Cipla bets on innovation for 10% revenue share; expands US manufacturing to de-risk supply chains  Storyboard18

Cipla bets on innovation for 10% revenue share; expands US manufacturing to de-risk supply chains - Storyboard18

Click here to get full coverage on Cipla names Shivam Puri as CEO of One India Business - MediaNews4U

Cipla names Shivam Puri as CEO of One India Business  MediaNews4U

Cipla names Shivam Puri as CEO of One India Business - MediaNews4U

Click here to get full coverage on Cipla Breaks Ventolin Barrier In US Generics - Citeline News & Insights

Cipla Breaks Ventolin Barrier In US Generics  Citeline News & Insights

Cipla Breaks Ventolin Barrier In US Generics - Citeline News & Insights

Click here to get full coverage on Fennec settles patent case with Cipla over generic PEDMARK - Investing.com

Fennec settles patent case with Cipla over generic PEDMARK  Investing.com

Fennec settles patent case with Cipla over generic PEDMARK - Investing.com

Click here to get full coverage on Hikma, Cipla Cut Deals In Pfizer Heart Drug Patent Case - Law360

Hikma, Cipla Cut Deals In Pfizer Heart Drug Patent Case  Law360

Hikma, Cipla Cut Deals In Pfizer Heart Drug Patent Case - Law360

Click here to get full coverage on Cipla Gets USFDA VAI Classification for Goa Manufacturing Facility - Medical Dialogues

Cipla Gets USFDA VAI Classification for Goa Manufacturing Facility  Medical Dialogues

Cipla Gets USFDA VAI Classification for Goa Manufacturing Facility - Medical Dialogues

Click here to get full coverage on Cipla appoints Shivam Puri as CEO-One India Business - Business Standard

Cipla appoints Shivam Puri as CEO-One India Business  Business Standard

Cipla appoints Shivam Puri as CEO-One India Business - Business Standard

Click here to get full coverage on Cipla had one of its worst quarters. Investors still rewarded it - The Ken

Cipla had one of its worst quarters. Investors still rewarded it  The Ken

Cipla had one of its worst quarters. Investors still rewarded it - The Ken

Click here to get full coverage on A Litany of Errors… and Cipla’s Patent Reinstated - Pearce IP

A Litany of Errors… and Cipla’s Patent Reinstated  Pearce IP

A Litany of Errors… and Cipla’s Patent Reinstated - Pearce IP

Click here to get full coverage on Cipla appoints Shivam Puri as CEO, One India Business - afaqs!

Cipla appoints Shivam Puri as CEO, One India Business  afaqs!

Cipla appoints Shivam Puri as CEO, One India Business - afaqs!

Click here to get full coverage on Cipla arm names Shivam Puri CEO of One India Business, effective 1 July 2026 - Business Standard

Cipla arm names Shivam Puri CEO of One India Business, effective 1 July 2026  Business Standard

Cipla arm names Shivam Puri CEO of One India Business, effective 1 July 2026 - Business Standard

Click here to get full coverage on Cipla Limited (NSE:CIPLA) Will Pay A ₹13.00 Dividend In One Day - simplywall.st

Cipla Limited (NSE:CIPLA) Will Pay A ₹13.00 Dividend In One Day  simplywall.st

Cipla Limited (NSE:CIPLA) Will Pay A ₹13.00 Dividend In One Day - simplywall.st

Click here to get full coverage on Fennec Pharmaceuticals reaches settlement with Cipla resolving Pedmark patent litigation - Drug Store News

Fennec Pharmaceuticals reaches settlement with Cipla resolving Pedmark patent litigation  Drug Store News

Fennec Pharmaceuticals reaches settlement with Cipla resolving Pedmark patent litigation - Drug Store News

Click here to get full coverage on Cipla recalls over 400 cartons of cancer drug in U.S.: USFDA - The Hindu

Cipla recalls over 400 cartons of cancer drug in U.S.: USFDA  The Hindu

Cipla recalls over 400 cartons of cancer drug in U.S.: USFDA - The Hindu

Click here to get full coverage on Cipla's Goa facility gets VAI status after US FDA inspection - Moneycontrol.com

Cipla's Goa facility gets VAI status after US FDA inspection  Moneycontrol.com

Cipla's Goa facility gets VAI status after US FDA inspection - Moneycontrol.com

Click here to get full coverage on Neutral Cipla; target of Rs 1310: Motilal Oswal - TradingView

Neutral Cipla; target of Rs 1310: Motilal Oswal  TradingView

Neutral Cipla; target of Rs 1310: Motilal Oswal - TradingView

Click here to get full coverage on Cipla Limited Just Missed EPS By 7.0%: Here's What Analysts Think Will Happen Next - simplywall.st

Cipla Limited Just Missed EPS By 7.0%: Here's What Analysts Think Will Happen Next  simplywall.st

Cipla Limited Just Missed EPS By 7.0%: Here's What Analysts Think Will Happen Next - simplywall.st

Click here to get full coverage on Cipla Goa facility gets VAI status from US FDA after inspection - BusinessLine

Cipla Goa facility gets VAI status from US FDA after inspection  BusinessLine

Cipla Goa facility gets VAI status from US FDA after inspection - BusinessLine

Click here to get full coverage on CIPLA: FY26 revenue rose to ₹28,162.59 crore; net profit was ₹3,861.74 crore; ₹13 dividend proposed - TradingView

CIPLA: FY26 revenue rose to ₹28,162.59 crore; net profit was ₹3,861.74 crore; ₹13 dividend proposed  TradingView

CIPLA: FY26 revenue rose to ₹28,162.59 crore; net profit was ₹3,861.74 crore; ₹13 dividend proposed - TradingView

Click here to get full coverage on "The reason we chose Cipla for partnership is that it has a strong distribution network across India. They have reach in areas we are not located. This will help us reach more patients," said Winselow Tucker of Eli Lilly and Company talking about the company's - LinkedIn

"The reason we chose Cipla for partnership is that it has a strong distribution network across India. They have reach in areas we are not located. This will help us reach more patients," said Winselow Tucker of Eli Lilly and Company talking about the company's  LinkedIn

"The reason we chose Cipla for partnership is that it has a strong distribution network across India. They have reach in areas we are not located. This will help us reach more patients," said Winselow Tucker of Eli Lilly and Company talking about the company's - LinkedIn

Click here to get full coverage on Cipla names Shivam Puri as CEO of One India Business - IMPACT Magazine

Cipla names Shivam Puri as CEO of One India Business  IMPACT Magazine

Cipla names Shivam Puri as CEO of One India Business - IMPACT Magazine

Click here to get full coverage on Sun Pharma, Cipla recall products in US over manufacturing issues: USFDA - The Economic Times

Sun Pharma, Cipla recall products in US over manufacturing issues: USFDA  The Economic Times

Sun Pharma, Cipla recall products in US over manufacturing issues: USFDA - The Economic Times

Click here to get full coverage on Key facts: Cipla Q4 EBITDA INR9.5bn; JPMorgan upgrade; US run‑rate $800–950m; shares up 8% - TradingView

Key facts: Cipla Q4 EBITDA INR9.5bn; JPMorgan upgrade; US run‑rate $800–950m; shares up 8%  TradingView

Key facts: Cipla Q4 EBITDA INR9.5bn; JPMorgan upgrade; US run‑rate $800–950m; shares up 8% - TradingView

Click here to get full coverage on Parag Parikh Flexi Cap Fund : ITC, HDFC Bank and Cipla among stocks bought and sold in May - The Economic Times

Parag Parikh Flexi Cap Fund : ITC, HDFC Bank and Cipla among stocks bought and sold in May  The Economic Times

Parag Parikh Flexi Cap Fund : ITC, HDFC Bank and Cipla among stocks bought and sold in May - The Economic Times

Click here to get full coverage on Cipla soars 8% despite disappointing Q4; what's driving pharma stock? - Business Standard

Cipla soars 8% despite disappointing Q4; what's driving pharma stock?  Business Standard

Cipla soars 8% despite disappointing Q4; what's driving pharma stock? - Business Standard

Click here to get full coverage on Cipla Shares Drop 2% as US FDA Approves Rival's Generic Advair Inhaler - scanx.trade

Cipla Shares Drop 2% as US FDA Approves Rival's Generic Advair Inhaler  scanx.trade

Cipla Shares Drop 2% as US FDA Approves Rival's Generic Advair Inhaler - scanx.trade

Click here to get full coverage on Cipla Names Achin Gupta As MD & Global CEO - BW Healthcare World

Cipla Names Achin Gupta As MD & Global CEO  BW Healthcare World

Cipla Names Achin Gupta As MD & Global CEO - BW Healthcare World

Click here to get full coverage on Cipla Q4 preview: Profit may plunge on weak US sales; check estimates here - Business Standard

Cipla Q4 preview: Profit may plunge on weak US sales; check estimates here  Business Standard

Cipla Q4 preview: Profit may plunge on weak US sales; check estimates here - Business Standard

Click here to get full coverage on What drives a ‘buy vs build vs partner’ decision in today’s pharmaceutical landscape? At the Asia Pacific M&A Summit 2026, Ashish Adukia, CFO, Cipla shares his perspective on making the right strategic call, balancing growth, capability, and long-term value i - LinkedIn

What drives a ‘buy vs build vs partner’ decision in today’s pharmaceutical landscape? At the Asia Pacific M&A Summit 2026, Ashish Adukia, CFO, Cipla shares his perspective on making the right strategic call, balancing growth, capability, and long-term value i  LinkedIn

What drives a ‘buy vs build vs partner’ decision in today’s pharmaceutical landscape? At the Asia Pacific M&A Summit 2026, Ashish Adukia, CFO, Cipla shares his perspective on making the right strategic call, balancing growth, capability, and long-term value i - LinkedIn

Click here to get full coverage on Cipla, Eli Lilly Join Forces to Launch Yurpeak in India - NAVLIN DAILY

Cipla, Eli Lilly Join Forces to Launch Yurpeak in India  NAVLIN DAILY

Cipla, Eli Lilly Join Forces to Launch Yurpeak in India - NAVLIN DAILY

Click here to get full coverage on Cipla, Sun Pharma recall drugs in US - ETPharma.com

Cipla, Sun Pharma recall drugs in US  ETPharma.com

Cipla, Sun Pharma recall drugs in US - ETPharma.com

Click here to get full coverage on Cipla weighs shifting Lanreotide production amid Rodopi FDA compliance hurdle - ETPharma.com

Cipla weighs shifting Lanreotide production amid Rodopi FDA compliance hurdle  ETPharma.com

Cipla weighs shifting Lanreotide production amid Rodopi FDA compliance hurdle - ETPharma.com

Click here to get full coverage on Cipla gains US FDA nod for Ventolin; analysts see $100 mn sales potential - Business Standard

Cipla gains US FDA nod for Ventolin; analysts see $100 mn sales potential  Business Standard

Cipla gains US FDA nod for Ventolin; analysts see $100 mn sales potential - Business Standard

Click here to get full coverage on Cipla: Tonic For The Patient Investor - BusinessLine

Cipla: Tonic For The Patient Investor  BusinessLine

Cipla: Tonic For The Patient Investor - BusinessLine

Click here to get full coverage on Cipla Gets USFDA Approval for Albuterol Inhaler, Expands US Respiratory Portfolio - Medical Dialogues

Cipla Gets USFDA Approval for Albuterol Inhaler, Expands US Respiratory Portfolio  Medical Dialogues

Cipla Gets USFDA Approval for Albuterol Inhaler, Expands US Respiratory Portfolio - Medical Dialogues

Click here to get full coverage on Accumulate Cipla; target of Rs 1400: Prabhudas Lilladher - TradingView

Accumulate Cipla; target of Rs 1400: Prabhudas Lilladher  TradingView

Accumulate Cipla; target of Rs 1400: Prabhudas Lilladher - TradingView

Click here to get full coverage on Cipla: Strong pipeline to help US business recovery - Moneycontrol.com

Cipla: Strong pipeline to help US business recovery  Moneycontrol.com

CIPLA

Price Chart

Key Statistics

Technicals

About CIPLA

Latest News

Lilly Sues Cipla to Block Copy of Breast Cancer Drug Verzenio - Bloomberg Law News

Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA - Yahoo Finance

Cipla Appoints Shivam Puri As CEO Of One India Business - BW Healthcare World

Advanced Charts

Top Gainers

Top Losers